Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): Feasibility Study

Phase 1

Completed

• Conditions: Tobacco Addiction; Smoking; Mental Health - Addiction; Infection - Acquired immune deficiency syndrome (AIDS / HIV)

• Registration Number: ACTRN12616001641482
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1.A diagnosis of HIV
2.Aged 18 years (or over)
3.Smoke 5 (or more) cigarettes per day, at the time of enrolment into the trial
4.Have been smoking for at least 12 months
5.Have capacity to consent and able to understand study instructions and procedures (e.g. sufficient English language ability).
6.Willing to attempt to quit tobacco smoking within 1 week of enrolment

Exclusion Criteria

1.Currently participating in a smoking-cessation program
2.Aged <18 years
3.Currently pregnant, measured by self-report, with confirmation by self-administered pregnancy test where there is doubt, or planning to become pregnant during trial participation period
4.Currently breast-feeding (measured by self-report) or planning to be during trial participation period
5.Insufficient capacity to provide informed consent or complete the study requirements (e.g. completing surveys in English)
6.Has experienced chest pain, or another cardiovascular event or procedure (e.g. heart attack, stroke, insertion of stent, bypass surgery) in the last month
7.Being treated with oxygen therapy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified